Jean-Claude Cutz

Jean-Claude Cutz

UNVERIFIED PROFILE

Are you Jean-Claude Cutz?   Register this Author

Register author
Jean-Claude Cutz

Jean-Claude Cutz

Publications by authors named "Jean-Claude Cutz"

Are you Jean-Claude Cutz?   Register this Author

40Publications

1519Reads

39Profile Views

Reactive Nodular Fibrous Pseudotumor Mimicking Metastatic Gastrointestinal Stromal Tumor to Perigastric Lymph Node: A Case Report and Review of the Literature.

Int J Surg Pathol 2018 Oct 23;26(7):664-670. Epub 2018 Apr 23.

1 McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1066896918771192DOI Listing
October 2018

Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development.

Transl Oncol 2018 Aug 30;11(4):1012-1022. Epub 2018 Jun 30.

Division of Nephrology, Department of Medicine, McMaster University, St. Joseph's Hospital, Hamilton, Ontario, Canada; the Research Institute of St Joe's Hamilton, St. Joseph's Hospital, Hamilton, Ontario, Canada; the Hamilton Center for Kidney Research, St. Joseph's Hospital, Hamilton, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2018.06.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031255PMC
August 2018

Genomic DNA Methylation-Derived Algorithm Enables Accurate Detection of Malignant Prostate Tissues.

Front Oncol 2018 23;8:100. Epub 2018 Apr 23.

Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925605PMC
April 2018

A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574).

Clin Lung Cancer 2017 07 31;18(4):436-440.e1. Epub 2017 Jan 31.

Division of Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada; Department of Oncology, McMaster University, Hamilton, Ontario, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.01.007DOI Listing
July 2017

Amplification of MUC1 in prostate cancer metastasis and CRPC development.

Oncotarget 2016 Dec;7(50):83115-83133

Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347757PMC
December 2016

Developing ALK Immunohistochemistry and In Situ Hybridization Proficiency Testing for Non-Small Cell Lung Cancer in Canada: Canadian Immunohistochemistry Quality Control Challenges and Successes.

Appl Immunohistochem Mol Morphol 2015 Nov-Dec;23(10):677-81

*Laboratory Medicine Program, University Health Network, University of Toronto, Toronto ‡Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON †Canadian Immunohistochemistry Quality Control §Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000267DOI Listing
August 2016

Characterization of Proliferating Lesion-Resident Cells During All Stages of Atherosclerotic Growth.

J Am Heart Assoc 2016 08 15;5(8). Epub 2016 Aug 15.

Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada Hamilton Centre for Kidney Research, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.116.003945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015311PMC
August 2016

Local molecular analysis of indeterminate thyroid nodules.

J Otolaryngol Head Neck Surg 2015 Dec 1;44:52. Epub 2015 Dec 1.

Division of Otolaryngology and Head and Neck Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40463-015-0106-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666165PMC
December 2015

Novel function of Oncostatin M as a potent tumour-promoting agent in lung.

Int J Cancer 2015 Feb 7;136(4):831-43. Epub 2014 Jul 7.

Department of Microbiology & Immunology, McGill University, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29055DOI Listing
February 2015

Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.

J Thorac Oncol 2014 Oct;9(10):1449-58

*The Canadian Centre for Applied Research in Cancer Control, and the British Columbia Cancer Agency, Vancouver, British Columbia, Canada; †The British Columbia Cancer Agency, Vancouver, British Columbia, Canada; ‡Brock University, St. Catherines, Ontario, Canada; §Cancer Care Ontario and the Juravinski Cancer Centre, Hamilton, Ontario, Canada; ‖University Health Network and Princess Margaret Cancer Centre, Toronto, Ontario, Canada; ¶The Canadian Centre for Applied Research in Cancer Control, the British Columbia Cancer Agency and School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; #The University of British Columbia School of Population and Public Health, Vancouver, British Columbia, Canada; **Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada; ††The British Columbia Cancer Agency and The Canadian Centre for Applied Research in Cancer Control and the University of British Columbia, Vancouver, British Columbia, Canada; ‡‡Beatrice Hunter Cancer Research Institute and Dalhousie University, Halifax, Nova Scotia, Canada; §§The Vancouver General Hospital, Vancouver, British Columbia, Canada; ‖‖Fionna Stanley Hospital and Sir Charles Gairdner Hospital, Perth, Western Australia; ¶¶Université Laval, Québec, Canada; ##Vancouver General Hospital, The University of British Columbia, Vancouver, British Columbia, Canada; ***The Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada; †††Princess Margaret Cancer Centre, Toronto, Ontario, Canada; ‡‡‡University of Calgary, Foothills Medical Centre, Calgary, Alberta, Canada; §§§Foothills Medical Centre, Calgary, Alberta, Canada; ‖‖‖Memorial University, St. Johns, Newfoundland, Canada; ¶¶¶The Ottawa Hospital, Ottawa, Ontario, Canada; ###Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; ****The Vancouver General Hospital and The University of British Columbia, Vancouver, British

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165479PMC
October 2014

Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer.

J Thorac Oncol 2014 Sep;9(9):1255-63

*Department of Pathology and Molecular Medicine, McMaster University Health Sciences Centre and McMaster University, Hamilton, Ontario; †Department of Pathology, University Health Network, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario; ‡Department of Pathology, Jewish General Hospital and Lady David Institute, McGill University, Montreal, Québec; §Cross Cancer Institute and Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, Alberta; ‖Department of Molecular Pathology, University of Alberta Hospital, Edmonton, Alberta; ¶Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; #Department of Pathology, Aichi Cancer Center Hospital, Nagoya, Japan; **Department of Pathology, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia; ††Department of Pathology, McGill University Health Centre, Montreal, Québec; ‡‡Department of Human Genetics, McGill University, Montreal, Québec; §§Department of Pathology, Health Sciences North, Sudbury, Ontario; ‖‖Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta; ¶¶Department of Pathology, The Ottawa Hospital and University of Ottawa, Ottawa, Ontario; ##Centre hospitalier de l'Universite de Montreal, Montreal, Québec; ***Department of Pathology, London Health Sciences Centre, London, Ontario; †††Department of Molecular Genetics, University of Toronto, Toronto, Ontario; ‡‡‡Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA; §§§Pfizer Oncology Canada, Kirkland, Québec; and ‖‖‖Institut Universitaire de Cardiologie et de Pneumologie de Québec (Hôpital Laval), Université Laval, Québec, Québec.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000239DOI Listing
September 2014

Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma.

Oncotarget 2014 Sep;5(17):7406-19

Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada, Hamilton, Ontario, Canada. Father Sean O'Sullivan Research Institute, Hamilton, Ontario, Canada. The Hamilton Center for Kidney Research, St. Joseph's Hospital, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202132PMC
http://dx.doi.org/10.18632/oncotarget.1558DOI Listing
September 2014

Changes in PKM2 associate with prostate cancer progression.

Cancer Invest 2014 Aug 2;32(7):330-8. Epub 2014 Jun 2.

Division of Nephrology, Department of Medicine, McMaster University,1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07357907.2014.919306DOI Listing
August 2014

Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer.

J Clin Oncol 2014 Apr 24;32(10):1012-9. Epub 2014 Feb 24.

Sandjar Djalalov, Jaclyn Beca, and Jeffrey S. Hoch, Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital and Cancer Care Ontario; Sandjar Djalalov, Jaclyn Beca, Jeffrey S. Hoch, Murray Krahn, and Natasha B. Leighl, Canadian Centre for Applied Research in Cancer Control; Murray Krahn, Toronto Health Economics and Technology Assessment Collaborative; Ming-Sound Tsao and Natasha B. Leighl, Ontario Cancer Institute and Princess Margaret Cancer Centre, Toronto; and Jean-Claude Cutz, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1186DOI Listing
April 2014

Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin.

Eur J Cancer 2013 Nov 26;49(16):3537-46. Epub 2013 Jul 26.

Division of Nephrology, Department of Medicine, St. Joseph's Hospital, Hamilton, Ontario, Canada; Department of Surgery, McMaster University, St. Joseph's Hospital, Hamilton, Ontario, Canada; Father Sean O'Sullivan Research Institute, St. Joseph's Hospital, Hamilton, Ontario, Canada; The Hamilton Center for Kidney Research, St. Joseph's Hospital, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.06.032DOI Listing
November 2013

IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.

Biochim Biophys Acta 2012 Jun 2;1822(6):875-84. Epub 2012 Mar 2.

Division of Nephrology, Department of Medicine, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2012.02.019DOI Listing
June 2012

α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells.

Nat Commun 2011 ;2:307

Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 4A6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms1309DOI Listing
November 2011

Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.

Biochim Biophys Acta 2011 May 26;1813(5):683-94. Epub 2011 Jan 26.

Division of Nephrology, Department of Medicine, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2011.01.018DOI Listing
May 2011

Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.

Int J Radiat Oncol Biol Phys 2010 Sep 7;78(1):221-9. Epub 2010 Jul 7.

Department of Oncology, Juravinski Cancer Center and McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.03.005DOI Listing
September 2010

PTEN inhibits BMI1 function independently of its phosphatase activity.

Mol Cancer 2009 Nov 10;8:98. Epub 2009 Nov 10.

Division of Nephrology, Department of Medicine, McMaster University, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-8-98DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777864PMC
November 2009

Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.

Biochim Biophys Acta 2008 Nov 6;1782(11):642-8. Epub 2008 Sep 6.

Division of Nephrology, Department of Medicine, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2008.08.009DOI Listing
November 2008

Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148.

J Clin Oncol 2008 Sep 30;26(26):4319-25. Epub 2008 Jun 30.

Princess Margaret Hospital, University Health Network, Bras Family Drug Development Program, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.8808DOI Listing
September 2008

Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy.

Prostate 2007 Feb;67(2):162-71

Department of Cancer Endocrinology, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20508DOI Listing
February 2007

ATM activation is accompanied with earlier stages of prostate tumorigenesis.

Biochim Biophys Acta 2006 Oct 24;1763(10):1090-7. Epub 2006 Aug 24.

Department of Medicine, McMaster University, Hamilton, ON, Canada L8N 4A6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2006.08.026DOI Listing
October 2006

Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias.

Cancer Genet Cytogenet 2006 Sep;169(2):128-37

Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, 610 University Ave., Room 9-721, Toronto, Ontario, M5G 2M9 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2006.04.003DOI Listing
September 2006